FirstOnco is an advanced cancer panel test that specifically detects heritable, disease-causing gene mutations that are associated with cancer predisposition. This testing method can be performed for diagnostic and screening purposes.
Hereditary cancer is a type of cancer that is passed down from one generation to the next within a family. It occurs when a person inherits a gene mutation for cancer. It is important to note that not all individuals with these gene mutations will develop cancer, but their likelihood of developing certain types of cancer is higher than that of the general population. Approximately 10% of all cancer cases are considered hereditary.
A risk for hereditary cancer may be present if the following signs are witnessed on the same side of a person’s family:
FirstOnco by First Genomix uses a comprehensive panel that covers 345 genes associated with different types of hereditary cancer. The panel includes well-established cancer-related genes, in addition to candidate genes with potential association to cancer. The test also helps in diagnosing complex hereditary cancer syndromes along with their associated cancer types in the following categories:
After a positive result, genetic counseling is offered to the patient to discuss available medical and reproductive treatment options.
